Related Experiment Video
Updated: Sep 22, 2025
10:05
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
8.4K
Recurrent Pericarditis: a Stubborn Opponent Meets New Treatments in 2022
Tracy Hagerty1,2, Matthew A Kluge3, Martin M LeWinter3,4
1Cardiology Unit, University of Vermont Medical Center, 111 Colchester Avenue, Burlington, VT, 05401, USA. Tracy.hagerty@uvmhealth.org.
Current Cardiology Reports
|May 25, 2022
Summary
New therapies targeting the inflammasome show promise for treating idiopathic recurrent pericarditis. Interleukin-1 (IL-1)-directed agents like anakinra and rilonacept are effective in reducing disease markers and improving patient outcomes.
Area of Science:
- Cardiology
- Immunology
- Inflammation Research
Background:
- Idiopathic recurrent pericarditis presents a significant treatment challenge.
- The condition diminishes patients' quality of life.
- Current therapies offer limited efficacy for recurrent cases.
Purpose of the Study:
- To review current therapies for idiopathic recurrent pericarditis.
- To focus on novel therapeutic agents.
- To understand the inflammasome's role in pericarditis pathophysiology and IL-1-directed therapies.
Main Methods:
- Review of recent research on pericarditis therapies.
- Focus on the NLRP3 inflammasome pathway.
- Analysis of anti-IL-1 agents (anakinra, rilonacept) in preclinical and clinical studies.
Main Results:
- NLRP3 inflammasome components found in pericardial tissue of affected patients.
- Anti-IL-1 agents reduced NLRP3 expression in a mouse model.
- Anakinra and rilonacept demonstrated efficacy in human subjects with recurrent idiopathic pericarditis.
Conclusions:
- The NLRP3 inflammasome is a key player in idiopathic recurrent pericarditis.
- IL-1-directed therapies represent a significant advancement in treatment.
- Further research is needed to optimize timing, duration, and side effect profiles of these new agents.
Related Concept Videos
01:17Pericarditis III: Medical Management
33
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
33
01:22Pericarditis I: Introduction
27
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
27
01:19Pericarditis II: Clinical Features and Diagnostic Tests
36
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
36
01:14Myocarditis III: Medical Management
24
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
24
01:25Pericarditis IV: Nursing Management
65
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
65
01:27Myocarditis II: Clinical Features and Diagnostic Tests
34
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
34